Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in J Thromb Thrombolysis

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    March 2017
  1. STEPPICH B, Dobler F, Brendel LC, Hessling G, et al
    Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2017 Mar 18. doi: 10.1007/s11239-017-1495.
    PubMed     Text format     Abstract available


    February 2017
  2. CAPPELLARI M, Bovi P
    Early use of direct oral anticoagulants after TIA/stroke in patients with atrial fibrillation: a 2016 update.
    J Thromb Thrombolysis. 2017 Feb 6. doi: 10.1007/s11239-017-1475.
    PubMed     Text format    


  3. MARSICO F, Cecere M, Parente A, Paolillo S, et al
    Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.
    J Thromb Thrombolysis. 2017;43:139-148.
    PubMed     Text format     Abstract available


    November 2016
  4. ZIRLIK A, Bode C
    Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  5. BASARAN O, Dogan V, Beton O, Tekinalp M, et al
    Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  6. HALE ZD, Kong X, Haymart B, Gu X, et al
    Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  7. LAU YC, Xiong Q, Blann AD, Lip GY, et al
    Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  8. SO CH, Eckman MH
    Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  9. LAU YC, Xiong Q, Shantsila E, Lip GY, et al
    Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  10. KHAN F, Huang H, Datta YH
    Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  11. ROSWELL RO, Greet B, Shah S, Bernard S, et al
    Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias.
    J Thromb Thrombolysis. 2016;42:179-85.
    PubMed     Text format     Abstract available


    July 2016
  12. RILINGER J, Meyer M, Schnabel K, Weik P, et al
    High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  13. CAPPELLARI M, Carletti M, Danese A, Bovi P, et al
    Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  14. MINHAS AS, Jiang Q, Gu X, Haymart B, et al
    Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


  15. SAJI N, Kimura K, Tateishi Y, Fujimoto S, et al
    Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  16. YAVUZ B, Ayturk M, Ozkan S, Ozturk M, et al
    A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  17. LAU YC, Xiong Q, Ranjit P, Lip GY, et al
    Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis.
    J Thromb Thrombolysis. 2016.
    PubMed     Text format     Abstract available


    February 2015
  18. JACKSON LR 2ND, Peterson ED, Okeagu E, Thomas K, et al
    Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials.
    J Thromb Thrombolysis. 2015;39:222-7.
    PubMed     Text format     Abstract available


  19. ROGNONI C, Marchetti M, Quaglini S, Liberato NL, et al
    Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis.
    J Thromb Thrombolysis. 2015;39:149-54.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: